Sermorelin + Ipamorelin: The Entry GH Blend

🧪 Load this blend into the DIY blend calculator →

What it is

Sermorelin with Ipamorelin is often called the gentler starting point among GH-axis blends. A GH-axis blend is a pair of research molecules that work along the body's growth hormone signaling pathway. Sermorelin is a short GHRH analog. GHRH stands for Growth Hormone Releasing Hormone, a natural signal the body uses to prompt growth hormone release. An analog is a molecule built to closely copy that natural signal. Sermorelin has a long research history. Ipamorelin is a selective GHRP, short for growth hormone releasing peptide. A GHRP is a different type of molecule that also prompts growth hormone release, but through a separate pathway.

Key point: This pairing is designed as a milder, highly pulsatile alternative to longer-acting growth hormone secretagogue blends. Pulsatile means the signal fires in short, quick bursts rather than staying active for a long stretch. A secretagogue is simply a molecule that signals the body to release another substance.

Why these are combined

Like the CJC-1295 + Ipamorelin blend, this is a GHRH-plus-GHRP pairing. Think of it like two different keys that open the same lock from different angles. However, Sermorelin's shorter action makes the combined signal more pulsatile and self-limiting in research descriptions. Self-limiting means the signal naturally fades on its own instead of staying active for a long time. This pairing uses the same idea of combining two complementary signals, but with a shorter-acting releasing factor.

The components

• Sermorelin, a short GHRH analog studied for pulsatile GH release.
• Ipamorelin, a selective GHRP and secretagogue.

Reconstitution and blending

Both components reconstitute (meaning they dissolve into liquid) with bacteriostatic water and are commonly drawn together into one cartridge at the lab bench.

Our reconstitution and DIY blend calculators handle the per-cartridge volumes and beyond-use timing once you have decided what shares a cartridge.

Status in sport

Both substances are prohibited in sport under WADA S2. WADA is the World Anti-Doping Agency. S2 is the section of their banned list that covers growth hormone releasing factors and secretagogues. The ban applies at all times.

Related reading

• Sermorelin
• Ipamorelin
• Full peptide reference library and stacking guide
• Reconstitution and blend calculators

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What is the difference between Sermorelin and Ipamorelin in a GH-axis research blend?

Sermorelin is a short GHRH analog that mimics the body's natural GH-release signal; Ipamorelin is a selective GHRP acting through a separate pathway. Combined, they produce a dual-signal, pulsatile GH-axis stimulus studied at the lab bench.

Why is Sermorelin + Ipamorelin considered a milder GH secretagogue blend?

Sermorelin's shorter action means the combined signal fades quickly on its own, making the pairing more self-limiting and pulsatile than longer-acting analogs like CJC-1295 , a distinction frequently noted in GH-axis signaling research.

Are Sermorelin and Ipamorelin prohibited in competitive sport?

Yes. Both are banned at all times under WADA S2, the section of the prohibited list covering growth hormone releasing factors and secretagogues.

What the research community gets wrong about the Sermorelin + Ipamorelin blend

• "Milder" does not mean easier to handle. The word describes how the signal behaves in receptor studies, not how the powders behave in a vial. Both are lyophilized peptides that still need careful reconstitution, gentle swirling instead of shaking, and cold storage.
• A shorter-acting molecule is not automatically more stable on the shelf. Sermorelin's short action in signaling research says nothing about how long the dry powder or the reconstituted solution stays intact in the vial. Powder stability and signaling half-life are two separate things.
• Sermorelin is not the same as CJC-1295. People lump all GHRH-type molecules together, but sermorelin is the short native GHRH(1-29) fragment sequence, while CJC-1295 is a modified, longer-acting construct. Treating them as interchangeable at the bench leads to wrong assumptions about solubility and handling.
• Sharing one cartridge is a decision, not a default. Two peptides being drawn together is common, but it does not mean every pair belongs in the same cartridge. Check each component's own solubility and storage window before combining, rather than assuming the blend inherits the friendlier of the two.
• "Pulsatile" and "self-limiting" are research descriptions, not selling points. These terms come from GH-axis signaling studies of the separate molecules. They describe how a signal fires and fades in that research context, and they are not claims about any outcome in a person.

From our bench: If you have reconstituted sermorelin and ipamorelin together in a single cartridge, tell us what you actually saw. Did the combined solution stay clear, or did you notice any cloudiness, particles, or color change over the days it sat under refrigeration? Note the storage temperature you used and roughly how long the solution stayed visibly clear. We want your real observations, not numbers we made up.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. PubChem , Ipamorelin (CID 9831659), C38H49N9O5
5. PubChem , Sermorelin (CID 16132413), GHRH analog
6. Raun K et al., Ipamorelin, the first selective growth hormone secretagogue, Eur J Endocrinol 1998